US HB4134 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on June 14 2023 - 25% progression
Action: 2023-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 14 2023 - 25% progression
Action: 2023-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.
Title
Updated Drug Labeling for Patient Safety Act
Sponsors
| Rep. Adam Schiff [D-CA] | Rep. Ann Kuster [D-NH] | Rep. Nanette Barragan [D-CA] | Rep. Paul Tonko [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-16 | House | Referred to the Subcommittee on Health. |
| 2023-06-14 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-14 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/4134/all-info |
| Text | https://www.congress.gov/118/bills/hr4134/BILLS-118hr4134ih.pdf |
